Background: To prevent malaria among children aged 3–59 months in areas with high
seasonal transmission, seasonal malaria chemoprevention (SMC) is recommended. In …

Seasonal malaria chemoprevention (SMC) for children under 5 years of age for up to four
monthly cycles during malaria transmission season was recommended by the WHO in 2012 …

Background Malaria transmission is highly seasonal in Niger. Despite the introduction of
seasonal malaria chemoprevention (SMC) in the Magaria District, malaria incidence …

Epidemiological observations have linked increased host iron with malaria susceptibility,
and perturbed iron handling has been hypothesized to contribute to the potentially life …

Background The burden of malaria remains the highest in sub-Saharan Africa and South
Sudan is not an exception. The country has borne the brunt of years of chronic warfare and …

Preventive chemotherapy interventions have been identified as key tools for malaria
prevention and control. Although a large number of publications have reported on the …

Background Burkina Faso implemented the seasonal malaria chemoprevention (SMC) in
2014 in seven pilot health districts, following the new recommendation by the WHO in 2012 …

Sulfadoxine-pyrimethamine plus amodiaquine is delivered to children aged 3–59 months as
seasonal malaria chemoprevention (SMC) in areas where transmission is highly seasonal …

Background Seasonal malaria chemoprevention (SMC) has been shown to be highly
efficacious against clinical malaria in areas where transmission is acutely seasonal. SMC …

The development of a highly effective vaccine against the pathogenic blood-stage infection
of human malaria will require a delivery platform that can induce an antibody response of …